Natera, Inc.

NASDAQ:NTRA

Medical - Diagnostics & Research

Healthcare
$289.50 +0.98%

+$2.23 today

Market cap
$41.98B
Beta
1.54
P/E (TTM)
-143.0
EPS (TTM)
-$1.60
52W Low $131.81High $256.36

Volume 1.96M

Average 1.41M

NTRA Short-term Investments

Marketable securities and deposits the company expects to convert to cash within a year.

Natera, Inc.NASDAQ: NTRA

Short-term Investments · Q2 FY2026 · quarter ended Jun 2026

Short-term investments remains negative

Q2 FY2026 short-term investments was $0, compared with $15.98M a year earlier.

Context

  • Short-term investments amounted to 0.0% of total assets at the end of Q2 FY2026, down 0.9 pp from a year earlier.
  • Short-term investments increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether short-term investments keeps falling in the next quarterly balance sheet after a -100.0% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$0— QoQ
Last fiscal yearDec 2025
$0-100.0% YoY
Year agoJun 2025
$15.98M-100.0% since
Short-term Investments past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-100.0%——
1 year-100.0%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Short-term Investments history

USD · from the balance sheet

Latest · FY2025
0 USD
Year-over-year change
-100.0%

Short-term Investments vs competitors

How NTRA compares with its peers on the latest reported figures

  • NTRA's Jun 2026 short-term investments of $0 is the 6th highest of the 8 companies compared; the peer median is $72.23M.
  • Its year-over-year change of -100.0% is the lowest of 6, against a peer median of +19.5%.
  • Short-term investments amounts to 0.0% of total assets for NTRA, versus a peer median of 15.0%.
NTRA Competitors Peer median
Short-term Investments for NTRA and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
FLGTFulgent Genetics, Inc.Mar 2026$252.9M -0.1%-13.8%21.9%
VCYTVeracyte, Inc.Jun 2026$185.71M +83.5%+26.9%12.5%
PSNLPersonalis, Inc.Mar 2026$159.62M +39.2%+13.8%49.1%
WGSGeneDx Holdings Corp.Jun 2026$72.23M +19.5%—15.0%
SERASera Prognostics, Inc.Mar 2026$43.23M +5.5%-12.6%46.2%
NTRANatera, Inc.Jun 2026$0 -100.0%—0.0%
BLLNBillionToOne, Inc.Jun 2026$0 ——0.0%
MYGNMyriad Genetics, Inc.Mar 2026$0 ——0.0%
Peer median (excluding NTRA) $72.23M+19.5%+0.6%15.0%

Competitors are the stored peer set for NTRA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents84.39M466.09M642.1M945.59M1.08B
Short-term Investments829.9M432.3M236.88M22.69M0
Net Receivables122.07M244.39M278.29M314.17M296.53M
Inventory26.91M35.41M40.76M44.74M68.44M
Other Current Assets228K33.63M60.52M48.64M55.83M
Total Current Assets1.09B1.21B1.26B1.38B1.5B
Property, Plant & Equipment (Net)124.53M164.33M167.75M248.2M349.73M
Goodwill0000141.07M
Intangible Assets0000373.71M
Long-term Investments00000
Tax Assets0000109.69M
Other Non-current Assets18.82M18.33M15.4M36.72M36.9M
Total Non-current Assets143.35M182.66M183.15M284.92M1.01B
Total Assets1.24B1.39B1.44B1.66B2.51B
Account Payables27.21M31.15M15M34.92M33.16M
Short-term Debt50.05M80.35M80.4M80.36M80.32M
Tax Payables2.23M4.32M3.73M4.42M0
Deferred Revenue7.4M10.78M16.61M19.75M24.91M
Other Current Liabilities58.15M62.96M69.1M73.39M102.11M
Total Current Liabilities218.96M310.5M307.27M344.05M441.23M
Long-term Debt280.39M281.65M282.95M00
Deferred Tax Liabilities0000110.39M
Deferred Revenue (Non-current)21.32M20M19.13M16.84M17.06M
Other Non-current Liabilities1.48M007.84M108.47M
Total Non-current Liabilities364.23M378.23M369.1M121.27M354.4M
Total Liabilities583.18M688.73M676.37M465.32M795.62M
Common Stock10K11K11K12K14K
Retained Earnings(1.39B)(1.94B)(2.38B)(2.57B)(2.78B)
Accumulated OCI(2.29M)(16.36M)(3.09M)(344K)(258K)
Other Stockholders Equity00000
Minority Interest00000
Total Equity653.3M705.74M765.33M1.2B1.71B
Total Debt397.23M446.22M441.99M187.12M214.38M
Net Debt312.85M(19.87M)(200.1M)(758.47M)(861.76M)

Natera, Inc.

NASDAQ:NTRA

Intrinsic Alpha fair value

Locked

Current Price

$289.50

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.